ScienceDaily (Mar. 15, 2009) — A class of Alzheimer’s disease drugs currently studied in clinical trials appears to reduce damage caused by traumatic brain injury in animals, researchers at Georgetown University Medical Center report in an upcoming advance online publication of Nature Medicine.
